Latest News

Clinical trials are the way that doctors find out whether a new treatment is better than or equal to the currently available options. If you participate in a study you will most likely receive really great care. “There are more eyes on you,” explains Maryam Lustberg, MD, MPH, the director of the Center for Breast Cancer at Yale Cancer Center in New Haven, Connecticut

Despite smoking being a significant health risk leading to lung cancer, the disease remains a considerable concern for those who have never smoked. While cigarettes remain a dominant contributor, there are also other risk elements such as exposure to environmental toxins like radon gas, second-hand smoke and occupational risks.

Declines in the death rate for breast cancer have furthered overall progress in cancer mortality.

Marcella Nunez-Smith is laser-focused on eliminating inequities among marginalized people.

Today, Explained [a podcast] digs into the stigma associated with prostate cancer diagnosis like Defense Secretary Lloyd Austin’s, and the fear many men have of the exam itself.

Michael Leapman, MD, MHS, shares background and key findings from the study, “Temporal and regional patterns of prostate cancer positron emission tomography imaging among commercial insurance beneficiaries in the United States.”

New research illustrates remarkably lower use of immediate breast reconstruction in older women of Asian descent.

In a Q&A, Ilana Richman, MD, MHS, assistant professor of medicine (general medicine), discusses why overdiagnosis is a concern, the challenges of assessing the benefit of new screening technologies, and the risks and benefits people should weigh when considering preventative screening.

Henry S. Park, MD, MPH, participates in a Q&A for Lung Cancer Awareness Month.